ask="13.08"
ask_size="300"
average_daily_volume="1825740"
bid="12.76"
bid_size="100"
book_value="-0.09"
change="+0.60"
change_from_200_day_moving_average="1.65"
change_from_50_day_moving_average="0.79"
change_from_52_week_high="-1.51"
change_From_52_week_low="5.35"
change_in_percent="+4.89%"
close="12.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-0.90"
ex_dividend_date="N/A"
float_shares="94803000"
high="12.91"
high_52_weeks="14.38"
last_trade_date="2/27/2017"
last_trade_price="12.87"
last_trade_size="92947"
last_trade_time="4:00pm"
low="12.02"
low_52_weeks="7.52"
market_capitalization="1.65B"
moving_average_200_day="11.22"
moving_average_50_day="12.08"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="12.27"
pe_ratio="N/A"
peg_ratio="-0.25"
percent_change_from_200_day_moving_average="+14.69%"
percent_change_from_50_day_moving_average="+6.58%"
percent_change_from_52_week_high="-10.50%"
percent_change_from_52_week_low="+71.14%"
previous_close="12.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.83"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="HALO"
volume="1538665"
weeks_range_52="7.52 - 14.38"
